When prescribed through a licensed provider, yes
Skin moisturizing improved by 13.1%, skin texture improved by 9%, skin density improved by 6.2%, skin elasticity improved by 4.8%, skin melanin improved by 3.2%, skin moisture loss reduced by 7.5%, eye wrinkle reduced by 12.1%, and freckle and blemish reduction by 12.5%
Seek immediate medical attention for: Severe, persistent abdominal pain, especially if different from typical IBS pain or radiating to the back (possible pancreatitis) Persistent vomiting preventing adequate fluid intake Signs of dehydration (decreased urination, dizziness, extreme thirst) Severe constipation lasting more than 3-4 days without bowel movement Blood in stool or black, tarry stools Yellowing of skin/eyes, right upper quadrant pain (possible gallbladder disease) Markedly reduced urination (possible acute kidney injury) Fever accompanying gastrointestinal symptoms Neck mass, difficulty swallowing, persistent hoarseness (thyroid concerns) Allergic reactions (rash, itching, swelling, severe dizziness) Scheduled follow-up should occur within 4-6 weeks of initiating therapy and after each dose escalation
This synergistic effect translates to better outcomes for many patients who find traditional GLP-1 therapy insufficient or who develop tolerability issues over time
